Skip to main content
Premium Trial:

Request an Annual Quote

WCG, InformedDNA Partner on Precision Medicine Clinical Trial Consulting

NEW YORK (GenomeWeb) WIRB-Copernicus Group (WCG) today said that its Clinical Services Division has entered a strategic partnership with InformedDNA, under which the companies will create a new "Center for Genetics and Precision Medicine in Clinical Trials," offering support services to biopharmaceutical companies, contract research organizations, and academic institutions in the design and conduct of precision medicine clinical trials.

Under the partnership, WCG and InformedDNA hope to combine InformedDNA's genetics resources and expertise with WCG's global network of 550 experts in clinical trial optimization and its proprietary industry Knowledge Base.  The planned center will offer customers guidance in applying genetics to the design trials, and to identify, recruit, and manage patients.

"With the rise in precision medicine, protocols have become increasingly complex," InformedDNA Chairman and CEO David Nixon said in a statement. "Through our partnership with WCG, we will teach research sponsors how to effectively apply genetic expertise to their studies so that they can derive the most value from their research," he added.

Patient engagement and subject recruitment will be a large part of the services, the companies said, combining WCG's experience in driving study enrollment in rare disease populations and InformedDNA's global network of genetic datasets.  As part of the new center, the companies will also offer genetic counseling and genetic test interpretation services to patients and investigators.

Financial terms of the agreement were not disclosed.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.